Search Results - "Butowski, Nicholas"

A Scoping Review of Exercise Oncology in the Primary Brain Tumor Patient–Caregiver Dyad.

Authors: Vo, Anh Huan Libmann, Maximilian Carson, David et al.

Source: Current Oncology. Apr2026, Vol. 33 Issue 4, p193. 17p.

Primary brain tumours in adults.

Authors: Lapointe, Sarah Perry, Arie Butowski, Nicholas A.

Source: Lancet. 8/4/2018, Vol. 392 Issue 10145, p432-446. 15p.

Subjects: Brain tumors, Central nervous system, Molecular biology, Glioma treatment, Radiotherapy, Brain tumor diagnosis, Brain tumor treatment, Gliomas, Prognosis, Diagnosis

Phase Ib/II Study of Pamiparib Plus Radiation Therapy and/or Temozolomide in Adult Patients with Treatment-Naïve or Recurrent/Refractory Glioblastoma.

Authors: Piotrowski, Anna F. Shih, Kent Giglio, Pierre et al.

Source: Current Oncology. Oct2025, Vol. 32 Issue 10, p541. 18p.

Rindopepimut with temozolomide for patients with newly diagnosed, EGFRvIII-expressing glioblastoma (ACT IV): a randomised, double-blind, international phase 3 trial.

Authors: Weller, Michael Butowski, Nicholas Tran, David D et al.

Source: Lancet Oncology. Oct2017, Vol. 18 Issue 10, p1373-1385. 13p.

A phase II study of concurrent temozolomide and cis-retinoic acid with radiation for adult patients with newly diagnosed supratentorial glioblastoma

Authors: Butowski, Nicholas Prados, Michael D. Lamborn, Kathleen R. et al.

Source: International Journal of Radiation Oncology, Biology, Physics. Apr2005, Vol. 61 Issue 5, p1454-1459. 6p.

Subjects: Isotretinoin, Supratentorial brain tumors, Patients, Clinical trials

Tele-cognitive rehabilitation for adult lower-grade glioma: An interim prospective pilot feasibility study.

Authors: Weyer-Jamora, Christina Brie, Melissa S Bracci, Paige M et al.

Source: Neuro-Oncology Practice. Feb2026, Vol. 13 Issue 1, p126-138. 13p.

Functional prediction of response to therapy prior to therapeutic intervention is associated with improved survival in patients with high-grade glioma.

Authors: Ledford, Aubrey Rodriguez, Analiz Lipinski, Lindsay et al.

Source: Scientific Reports. 8/29/2024, Vol. 14 Issue 1, p1-16. 16p.

Clinical trial endpoints for patients with gliomas.

Authors: Taylor, Jennie W. Molinaro, Annette M. Butowski, Nicholas et al.

Source: Neuro-Oncology Practice. Dec2017, Vol. 4 Issue 4, p201-208. 8p.

Automatic Brain Tissue and Lesion Segmentation and Multi-Parametric Mapping of Contrast-Enhancing Gliomas without the Injection of Contrast Agents: A Preliminary Study.

Authors: Liu, Jing Jakary, Angela Villanueva-Meyer, Javier E. et al.

Source: Cancers. Apr2024, Vol. 16 Issue 8, p1524. 17p.

A systematic review of high impact CpG sites and regions for MGMT methylation in glioblastoma [A systematic review of MGMT methylation in GBM].

Authors: Gibson, David Vo, Anh Huan Lambing, Hannah et al.

Source: BMC Neurology. 3/23/2024, Vol. 24 Issue 1, p1-13. 13p.

Go, no-go decision making for phase 3 clinical trials: ACT IV revisited - Authors' reply.

Authors: Weller, Michael Butowski, Nicholas Tran, David D et al.

Source: Lancet Oncology. Dec2017, Vol. 18 Issue 12, pe709-e710. 2p.

A systematic review and meta-analysis examining the effects of cannabis and its derivatives in adults with malignant CNS tumors.

Authors: Rodriguez-Almaraz, Jesus-Eduardo Chang, Susan Clarke, Jennifer et al.

Source: Neuro-Oncology Practice. Aug2020, Vol. 7 Issue 4, p376-383. 8p.

Reirradiation of recurrent high-grade glioma and development of prognostic scores for progression and survival.

Authors: Chapman, Christopher H Hara, Jared H Molinaro, Annette M et al.

Source: Neuro-Oncology Practice. Oct2019, Vol. 6 Issue 5, p364-374. 11p.

Attitudes toward fertility and fertility preservation in women with glioma.

Authors: Stiner, Rachel K Clarke, Jennifer L Sinha, Nikita et al.

Source: Neuro-Oncology Practice. 2019, Vol. 6 Issue 3, p218-225. 8p.

Intratumor and informatic heterogeneity influence meningioma molecular classification.

Authors: Vasudevan, Harish N. Choudhury, Abrar Hilz, Stephanie et al.

Source: Acta Neuropathologica. Sep2022, Vol. 144 Issue 3, p579-583. 5p.

Randomized trial of neoadjuvant vaccination with tumor-cell lysate induces T cell response in low-grade gliomas.

Authors: Hirokazu Ogino Taylor, Jennie W. Nejo, Takahide et al.

Source: Journal of Clinical Investigation. Feb2022, Vol. 132 Issue 3, p1-13. 13p.

The immunohistochemical, DNA methylation, and chromosomal copy number profile of cauda equina paraganglioma is distinct from extra-spinal paraganglioma.

Authors: Ramani, Biswarathan Gupta, Rohit Wu, Jasper et al.

Source: Acta Neuropathologica. Dec2020, Vol. 140 Issue 6, p907-917. 11p.

Recurrent non-canonical histone H3 mutations in spinal cord diffuse gliomas.

Authors: Sloan, Emily A. Cooney, Tabitha Oberheim Bush, Nancy Ann et al.

Source: Acta Neuropathologica. Nov2019, Vol. 138 Issue 5, p877-881. 5p.

The genetic landscape of gliomas arising after therapeutic radiation.

Authors: López, Giselle Y. Van Ziffle, Jessica Onodera, Courtney et al.

Source: Acta Neuropathologica. Jan2019, Vol. 137 Issue 1, p139-150. 12p.

Probing the phosphatidylinositol 3-kinase/mammalian target of rapamycin pathway in gliomas: A phase 2 study of everolimus for recurrent adult low-grade gliomas.

Authors: Wahl, Michael Chang, Susan M. Phillips, Joanna J. et al.

Source: Cancer (0008543X). Dec2017, Vol. 123 Issue 23, p4631-4639. 9p.